Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,094 public trials 2,044 recruiting studies

Lymphoproliferative Disorders trial results

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • UCLA Los Angeles, California, United States
  • University Miami Miami, Florida, United States
  • Stony Brook University Hospital Stony Brook, New York, United States
  • Columbia Basin Hem-Onc; Department Hematology Oncology Kennewick, Washington, United States
View all 19 locations
Conditions
Dermatitis, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arizona, United States
  • Belleair Research Center, LLC Pinellas Park, Florida, United States
  • Kansas City Dermatology, PA Overland Park, Kansas, United States
  • Dermatology Specialists Louisville, Kentucky, United States
View all 40 locations
Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Irccs Centro Di Riferimento Oncologico Di Aviano (Pn) Aviano, Italia, Italy
  • Policlinico S.Orsola Malpighi Bologna, Italy
  • Irccs Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale Di Napoli Naples, Italy
Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +18 more
Locations
  • Oncotherapeutics West Hollywood, California, United States
  • Rocky Mountain Cancer Centers RMCC Greenwood Village, Colorado, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
  • Novartis Investigative Site Isehara, Kanagawa, Japan